Written Question·Department of Health and Social Care·UIN 83210
Abiraterone
Tabled: 17 October 2025
Answered: 24 October 2025
Question
Danny Beales
Labour — Uxbridge and South Ruislip
To ask the Secretary of State for Health and Social Care, whether the NICE guidance on abiraterone produced in 2021 was based on abiraterone's cost in generic form.
Answer
Dr Zubir AhmedThe National Institute for Health and Care Excellence’s (NICE) published guidance on abiraterone for treating newly diagnosed high-risk hormone-sensitive metastatic prostate cancer, which has the reference code TA721, was developed before the patent for a...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 83210) →